Targeted filgrastim support in patients with early-stage breast carcinoma: toward the implementation of a risk model
| Autor: | Gabriel N. Hortobagyi, Moshe Fridman, Edgardo Rivera, Chris A. Knight, M. Haim Erder, Timothy David Moore, Carol Brannan, Laurence Danel-Moore, Thomas L. Shiftan |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Adult
Cancer Research medicine.medical_specialty Neutropenia Filgrastim Breast Neoplasms Risk model Risk Factors Antineoplastic Combined Chemotherapy Protocols Granulocyte Colony-Stimulating Factor medicine Humans In patient Prospective Studies Aged Neoplasm Staging business.industry Middle Aged University hospital Recombinant Proteins Surgery Oncology Neoplasm staging Female General health business Humanities |
| Zdroj: | Cancer. 98(2) |
| ISSN: | 0008-543X |
| Popis: | AMF Consulting Incorporated, Los Angeles, Cal-ifornia.The authors thank William Carter, Ph.D., and theOncology Practice Pattern Study Group for provid-ing the historic-control database. MaryAnn Foote,Ph.D., assisted with the writing of this article.Additional members of the Neutropenia Risk ModelStudy Group include: Mitchell Alden, M.D., Bux-Mont Oncology/Hematology Medical Associates,Sellersville, PA; Francis P. Arena, M.D., Arena On-cology Associates, Great Neck, NY; John A. Axel-son, M.D., Hematology/Oncology Association ofSouthern Michigan, Jackson, MI; Suzanne T. Ber-lin, M.D., Addison-Gilbert Hospital, Gloucester, MA;Stephanie Bernstein, M.D., Faulkner Hospital, Ja-maica Plains, MA; Rachel Borson, M.D., MidwestCancer Center, St. Louis, MO; Albert M. Brady,M.D., St. Joseph Mercy Oakland, Pontiac, MI; Mi-chael S. Buchholtz, M.D., Hematology/Oncology,Huntington, NY; Janak E. Choksi, M.D., AlamanceCancer Center, Burlington, NC; Patrick Colarusso,M.D., Pottstown Memorial Cancer Center, Potts-town, PA; Elliot Dickman, M.D., Hillcrest HospitalCancer Center, Mayfield Heights, OH; David Dun-ning, M.D., Northern Virginia Oncology Group, Fair-fax,VA;LeroyJ.Essig,M.D.,MedicalSpecialistsofFredericksburg, Fredericksburg, VA; Frank J.Forte, M.D., Staten Island University Hospital,Staten Island, NY; Julio M. Garcia, M.D., Oncology/RadiationAssociates,Miami,FL;JeremyR.Geffen,M.D., Geffen Cancer Center, Vero Beach, FL;Charles D. Graham, M.D., Trident Palmetto Hema-tology/Oncology, Charleston, SC; Andrew A.Hertler, M.D., Maine General Health, Waterville,ME; Karen L. Hoelzer, M.D., Springfield Clinica,Springfield, IL; Anthony D. Hoffman, M.D., SciodeMedical Association, Bronx, NY; Leonard A. Kal-man, M.D., Oncology/Hematology Group of SouthFlorida, Miami, FL; Edward H. Kaplan, M.D., NorthShoreCancerResearch,Skokie,IL;JosephKaplan,M.D., Community Hematology/Oncology, Olney,MD; Kapisthalam S. Kumar, M.D., Pasco HernandoOncology Associates, New Port Richey, FL; StevenS. Larmon, M.D., Dartmouth-Hitchcock Hospital,Keene, NH; James J. Lechner, M.D., WesternWashington Oncology, Olympia, WA; William A.Lerner, M.D., Topilow, Lerner & Mencel, Man-asquan, NJ; James E. Liebmann, M.D., New Mex-ico Oncology/Hematology Consultants, Albuquer-que, NM; Robert J. March, M.D., Hematology/Oncology Associates, New City, NY; Leslie A.Martin, M.D., St Elizabeth’s Medical Center, Brigh-ton, MA; Edward T. O’Brien, M.D., The RegionalCancer Center, Erie, PA; John A. Okerbloom, M.D.,Heartland Oncology & Hematology, Council Bluffs,IA; James M. Orsini, M.D., Essex Hematology/Oncology Group, Belleville, NJ; Stuart H. Packer,M.D., Hematology/Oncology, Langhorne, PA; Sig-urdur R. Petursson, M.D., Western PennsylvaniaHospital, Pittsburgh, PA; Debra M. Prow, M.D.,Texas Cancer Center, Fort Worth, TX; Jane M.Raymond, M.D., Western Pennsylvania Hospital,Pittsburgh, PA; Joseph A. Readling, M.D., LourdesRegional Cancer Center, Binghamton, NY; Joel H.Schwartz, M.D., North Shore Cancer Center, Pea-body, MA; David Shiba, M.D., Gould Medical Group,Modesto, CA; Michael J. Stender, M.D., Hematology/Oncology Consultants, Royal Oak, MI; N. SimonTchekmedyian, M.D., Pacific Shores Medical Group,Long Beach, CA; Kathleen Toomey, M.D., SomersetHematology/Oncology, Somerset, NJ; Dean Tsar-whas, M.D., North Shore Oncology/Hematology, Lib-ertyville, IL; Stephen A. Volk, M.D., Oncology/Hema-tology of Lehigh Valley, Bethlehem, PA; PivapongVongkovit, M.D., Northwestern Carolina Oncology/Hematology, Hickory, NC; and Marjorie A. Vukelich,M.D., Kettle Moraine Oncology, West Bend, WI.Address for reprints: Edgardo Rivera, M.D., Univer-sity of Texas M. D. Anderson Cancer Center, 1515Holcombe Blvd., Unit 424, Houston, TX 77030-0056; Fax: (713) 794-4385; E-mail: erivera@mail.mdanderson.orgReceived January 15, 2003; revision receivedMarch 28, 2003; accepted April 11, 2003. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text